Cytek Biosciences (CTKB) Income towards Parent Company (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Income towards Parent Company came in at -$18.9 million in Q1 2026, down 65.52% YoY from -$54.7 million in Q1 2025, and up 57.14% on a QoQ basis from -$44.0 million in Q4 2025.
Cytek Biosciences (CTKB) Income towards Parent Company (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Income towards Parent Company data on file, last reported at -$18.9 million in Q1 2026.
- Quarterly Income towards Parent Company fell 65.52% year-over-year to -$18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.0 million (down 555.85% YoY) and the FY2025 annual result came in at -$66.5 million, down 1005.3% from the prior year.
- Income towards Parent Company rose to -$18.9 million in Q1 2026, from -$44.0 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $9.6 million in Q4 2024 to a low of -$44.0 million in Q4 2025.
- A 5-year average of -$5.9 million and a median of -$5.5 million in 2025 frame the typical range for Income towards Parent Company.
- The widest YoY moves for Income towards Parent Company: up 419.14% in 2022, down 2215.69% in 2022.
- Tracing CTKB's Income towards Parent Company over 5 years: stood at $3.7 million in 2022, then surged by 48.01% to $5.5 million in 2023, then jumped by 74.5% to $9.6 million in 2024, then slumped by 558.49% to -$44.0 million in 2025, then soared by 57.14% to -$18.9 million in 2026.
- The last three Income towards Parent Company figures came in at -$18.9 million (Q1 2026), -$44.0 million (Q4 2025), and -$5.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 613.00 Mn | 539.15 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.16 Mn |
| Mar 31, 2026 | -18.87 Mn |
| Dec 31, 2025 | -44.03 Mn |
| Sep 30, 2025 | -5.47 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 957,000.00 |
| Jun 30, 2024 | -10.43 Mn |
| Mar 31, 2024 | -6.19 Mn |
| Dec 31, 2023 | 5.50 Mn |
| Sep 30, 2023 | -6.46 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -6.84 Mn |
| Dec 31, 2022 | 3.72 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | -702,000.00 |
| Mar 31, 2022 | -2.16 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 1.42 Mn |